Moreover, across these 4 types of solid tumor, CD4+ effector T cells and apCAFs exhibit a co-localized spatial distribution, indicating that apCAFs may be associated with anti-tumor effects by promoting the survival of CD4+ T cells. The gene discussed is CD4; the disease is neoplasm.